Because PRMT5 inhibition decreased HCC proliferation and induced BTG2 expression, we hypothesized that BTG2 functions downstream of PRMT5 in the proliferative regulation of HCC cells. The gene discussed is PRMT5; the disease is hepatocellular carcinoma.